Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

ClinicalTrials.gov ID: NCT04040192

Public ClinicalTrials.gov record NCT04040192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 6:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Maintenance Treatment and Flare Reduction With Crisaborole Ointment, 2%, Once Daily Over 52 Weeks in Pediatric and Adult Participants (Ages 3 Months and Older) With Mild-to-Moderate Atopic Dermatitis, Who Responded to Twice Daily Crisaborole Ointment, 2%, Treatment

Study identification

NCT ID
NCT04040192
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
620 participants

Conditions and interventions

Interventions

  • Crisaborole 2% Drug
  • Vehicle Drug

Drug

Eligibility (public fields only)

Age range
3 Months and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 11, 2019
Primary completion
Jan 18, 2022
Completion
Jan 18, 2022
Last update posted
Mar 7, 2023

2019 – 2022

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
First OC Dermatology Fountain Valley California 92708
Center for Dermatology Clinical Research, Inc. Fremont California 94538
Asthma and Allergy Associates, PC Colorado Springs Colorado 80907
Colorado Springs Dermatology Clinic, PC Colorado Springs Colorado 80910
Skin Care Research LLC Boca Raton Florida 33486
Clinical Neuroscience Solutions, Inc Jacksonville Florida 32256
Olympian Clinical Research Largo Florida 33770
Baumann Cosmetic and Research Institute Miami Florida 33137
Clinical Neuroscience Solutions, Inc Orlando Florida 32801
The Indiana Clinical Trials Center, PC Plainfield Indiana 46168
Meridian Clinical Research, LLC Baton Rouge Louisiana 70808
Great Lakes Research Group, Inc. Bay City Michigan 48706
Skin Specialists PC Omaha Nebraska 68144
Ohio Pediatric Research Association, Inc. Dayton Ohio 45414
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Oklahoma State University - Center for Health Sciences Tulsa Oklahoma 74127
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119
Innovate Research, LLC Fort Worth Texas 76244
Austin Institute for Clinical Research Houston Texas 77056
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660
Center for Clinical Studies, LTD. LLP Webster Texas 77598
Jordan Valley Dermatology Center South Jordan Utah 84095
PI-Coor Clinical Research LLC Burke Virginia 22015
Dermatology Specialists of Spokane Spokane Washington 99202
Principle Research Solutions Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04040192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2023 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04040192 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →